Sulis Therapeutics ApS — Credit Rating and Financial Key Figures

Sulis Therapeutics ApS (CVR number: 44445832) is a company from AARHUS. The company recorded a gross profit of -2 kEUR in 2023. The operating profit was -4.5 kEUR, while net earnings were -4.5 kEUR. The profitability of the company measured by Return on Assets (ROA) was -2.3 %, which can be considered poor and Return on Equity (ROE) was -2.9 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 79.7 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. Sulis Therapeutics ApS's liquidity measured by quick ratio was 1.2 which is at a high level. Thus, the company is in a strong financial position, with liquid assets surpassing current liabilities. It is well-prepared to cover short-term financial obligations.